CI
VIRX

Cowen Inc’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Cowen Inc’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-357
Closed – – 366
2015
Q4 		$0 Buy
+357
New +$66.8K ﹤0.01% 346
2015
Q3 		– Sell
-67
Closed -$24.2K – 451
2015
Q2 		$0 Buy
67
+31
+86% +$16.5K ﹤0.01% 532
2015
Q1 		$0 Buy
+36
New +$18.2K ﹤0.01% 454
2014
Q3 		– Sell
-206
Closed -$282K – 334
2014
Q2 		$282K Sell
206
-150
-42% -$174K 0.03% 204
2014
Q1 		$492K Sell
356
-2,959
-89% -$3.44M 0.06% 135
2013
Q4 		$3.3M Buy
3,315
+1,160
+54% +$1.2M 0.55% 33
2013
Q3 		$2.24M Buy
+2,155
New +$2.3M 0.33% 51

Other funds holding VIRX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cowen Inc's VIRX Position: Q1 2016 in Review

Cowen Inc sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q1 2016, closing a stake of 357 shares.

Cowen Inc first reported a position in VIRX in Q3 2013 and held it in 7 quarters. The position peaked at $3.3M in Q4 2013. 56 funds tracked by Wall St. Rank hold VIRX as of Q1 2016.

  • Cowen Inc reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Cowen Inc sold 357 Viracta Therapeutics, Inc. Common Stock shares in Q1 2016.
  • Cowen Inc first reported a position in Viracta Therapeutics, Inc. Common Stock in Q3 2013 and held it in 7 quarters.
  • Cowen Inc's Viracta Therapeutics, Inc. Common Stock position peaked at $3.3M in Q4 2013.
  • 56 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q1 2016.

Based on Cowen Inc's 13F filing for Q1 2016, filed 16 May 2016.